Embolization Agents Market Global Analysis & Forecast 2028
The embolization agents market is projected to reach US$ 4,525.75 million by 2028 from US$ 2,714.82 million in 2021; it is expected to grow at a CAGR of 7.6% from 2021 to 2028.
The growth of the market is attributed to the rising incidence of tumors and aneurysms and growing prevalence of hypertension, obesity, smoking, and alcoholism. However, high costs of embolization agents restrain the embolization agents market growth. Embolization agents are used to apply mechanical occlusion to stop the flow of blood in a blood vessel or vascular area. In interventional radiology, embolization is a common procedure. Embolization procedures are mostly used to treat traumatic injuries. Embolic agents come in a variety of forms, each with its own set of properties and applications. Depending on the duration required for arterial occlusion, embolization agents are classified as temporary or permanent.
In the US, the demand for warts treatment procedures has reduced due to the shift in the focus on COVID-19 treatment. The COVID-19 pandemic has been causing havoc in the global supply chains, consumer markets, and economies. This situation has led to a decline in cardiac procedures carried out in various countries in Asia Pacific. The measures implemented by governments across the world have negatively impacted the embolization agents market growth.
Customize Research To Suit Your Requirement
We can optimize and tailor the analysis and scope which is unmet through our standard offerings. This flexibility will help you gain the exact information needed for your business planning and decision making.
Embolization Agents Market: Strategic Insights
Market Size Value in US$ 2,714.82 million in 2021 Market Size Value by US$ 4,525.75 million by 2028 Growth rate CAGR of 7.6% from 2021-2028. Forecast Period 2021-2028 Base Year 2021
Mrinal
Have a question?
Mrinal will walk you through a 15-minute call to present the report’s content and answer all queries if you have any.
Speak to Analyst
Customize Research To Suit Your Requirement
We can optimize and tailor the analysis and scope which is unmet through our standard offerings. This flexibility will help you gain the exact information needed for your business planning and decision making.
Embolization Agents Market: Strategic Insights
![embolization-agents-market](https://www.theinsightpartners.com/assets/rdimages/embolization-agents-market-img1.png)
Market Size Value in | US$ 2,714.82 million in 2021 |
Market Size Value by | US$ 4,525.75 million by 2028 |
Growth rate | CAGR of 7.6% from 2021-2028. |
Forecast Period | 2021-2028 |
Base Year | 2021 |
![Analyst Image](https://www.theinsightpartners.com/assets/mrinal_kerhalkar.jpg)
Mrinal
Have a question?
Mrinal will walk you through a 15-minute call to present the report’s content and answer all queries if you have any.
![Analyst Image](https://www.theinsightpartners.com/assets/images/speak_analyst.gif)
Market Insights
Rising Incidence of Tumors and Aneurysms Fuels Embolization Agents Market Growth
According to the National Cancer Institute, in 2020, there were 1,806,590 new cancer cases and 606,520 deaths due to the disease in the US. In 2020, prostate, lung, and colorectal cancers accounted for 43 % of all cancers diagnosed in men. Breast, lung, and colorectal cancers are the three most frequent cancers diagnosed in women. As per the Brain Aneurysm Foundation, Statistics and Facts report, in the US, around 6.5 million people that is 1 in 50 people have an unruptured brain aneurysm. It has also mentioned that 20% of the total people diagnosed with a brain aneurysm have more than one aneurysm. It has further reported that, every year, around 30,000 people in the US suffer from a brain aneurysm rupture and a brain aneurysm rupture takes place every 18 minutes. Further, as per the NHS, every year in the UK, 1 in 12,500 people have a ruptured brain aneurysm in England. Additionally, as per the ‘Unruptured Intracranial Aneurysms Pathogenesis and Individualized Management’ report published in Deutsches Ärzteblatt International in 2020, around 2 million people (adults) in Germany have an unruptured intracranial aneurysm (IA). Embolization agents are used to acutely stop the flow in a blood vessel or vascular territory by the means of mechanical occlusion. Embolizing agents, such as embolic microspheres (beads), are used to restrict the vascular supply to tumors and can be loaded with chemotherapeutic medicines, which elute and diffuse into the tissue. Liquid embolic agents are used to prevent blood supply to aneurysm or tumor. Thus, the increasing prevalence of aneurysms and cancers is creating high demand for embolization agents.
Product-Based Insights
Based on product, the embolization agents market is segmented into coils, beads/particles, plugs, detachable balloons, glue, sponge, liquid embolics, sclerosants, precipitating agents, and others. The beads/particles segment holds the largest share of the market. However, the coil segment is anticipated to register the highest CAGR during 2021–2028. Coil Embolization is a catheter-based procedure that allows precise occlusion of abnormal blood flow in a blood vessel. The increasing number of cardiac surgeries is propelling the market growth of this segment.
Application - Based Insights
Based on application, the embolization agents market is segmented into neurology, oncology, cardiology, peripheral vascular diseases, and others. The oncology segment holds the largest share of the market and is anticipated to register the highest CAGR in the market during the forecast period.
End User-Based Insights
Based on end user, the embolization agents market is segmented into hospitals, ambulatory surgical centers, cardiac centers, and others. The hospitals segment holds the largest market share and is estimated to register the highest CAGR during the forecast period. The market growth for this segment is attributed to the increasing number of hospitals across the world and rapidly growing number of surgical procedures.
Companies operating in the embolization agents market are adopting the product innovations strategy to meet the evolving customer demands across the world, which also permits them to maintain their brand name in the global market.
Embolization Agents Market Report Scope
Embolization Agents Market – by Product
- Coils
- Detachable Coils
- Pushable Coils
- Beads/ Particles
- Spherical
- Non-Spherical
- Plugs
- Detachable Balloons
- Glue
- Sponge
- Liquid Embolics
- Sclerosants
- Precipitating Agents
- Others
Embolization Agents Market – by Application
- Oncology
- Neurology
- Urology
- Cardiology
- Peripheral Vascular Diseases
- Others
Embolization Agents Market – by End User
- Hospitals
- Cardiac Centers
- Ambulatory Surgical Centers
- Others
Embolization Agents Market– by Geography
North America
- US
- Canada
- Mexico
Europe
- France
- Germany
- Italy
- UK
- Spain
- Rest of Europe
Asia Pacific (APAC)
- China
- India
- South Korea
- Japan
- Australia
- Rest of APAC
Middle East and Africa (MEA)
- South Africa
- Saudi Arabia
- UAE
- Rest of MEA
South and Central America (SCAM)
- Brazil
- Argentina
- Rest of SCAM
Company Profiles
- Medtronic
- Terumo Corporation
- Cook Medical LLC
- Boston Scientific Corporation
- Abbott
- Stryker Corporation
- Penumbra, Inc.
- Merit Medical Systems Inc.
- DePuy Synthes
- KANEKA CORPORATION
![Report Coverage](https://www.theinsightpartners.com/assets/rdimages/report_coverage.png)
Report Coverage
Revenue forecast, Company Analysis, Industry landscape, Growth factors, and Trends
![Segment Covered](https://www.theinsightpartners.com/assets/rdimages/segment_covered.png)
Segment Covered
Product, Application and End User
![Regional Scope](https://www.theinsightpartners.com/assets/rdimages/regional_scope.png)
Regional Scope
North America, Europe, Asia Pacific, Middle East & Africa, South & Central America
![Country Scope](https://www.theinsightpartners.com/assets/rdimages/country_scope.png)
Country Scope
Argentina, Australia, Brazil, Canada, China, France, Germany, India, Italy, Japan, Mexico, Saudi Arabia, South Africa, South Korea, Spain, United Arab Emirates, United Kingdom, United States
Frequently Asked Questions
The factors that are driving growth of the market are rising incidence of tumors and aneurysms, and growing incidence of hypertension, obesity, smoking, and alcoholism.
Embolization agents are used to apply mechanical occlusion to stop the flow of blood in a blood vessel or vascular area. In interventional radiology, embolization is a common procedure. Embolization procedures are most used to treat traumatic injuries. Embolic agents come in a variety of forms, each with its own set of properties and applications. Depending on the duration of time that arterial occlusion is required, embolization agents are classified as temporary or permanent.
Various companies have made organic growth strategies in the embolization agents market. Some of the activities undertaken by the company, which have promoted its growth are, launches, enhancements and expansion & relocation activities. Companies such as Medtronic, Cook Medical LLC amongst others are some of the companies that have been implementing various organic strategies that have helped the growth of the company.
Asia Pacific is expected to be the fastest growing region in the embolization agents market. The growth of the market in this region is primarily due to factors such as rising prevalence of the brain stroke, coronary artery diseases, heart diseases, increasing surgical procedures, growing number of hospitals and ambulatory surgeries centers, focus by industry players in Japan and developing healthcare infrastructure in India are likely to boost the market growth in forecast period.
The coil segment is growing at the highest CAGR owing to increasing number of cardiac surgeries.
North America dominates the global embolization agents market due to factors such as increasing incidences of the neurological disorders such as stroke, brain aneurysms and others across the country, increasing product launches, well-developed healthcare facility centres equipped with modern-age equipment and instruments.
1. Introduction
1.1 Scope of the Study
1.2 The Insight Partners Research Report Guidance
1.3 Market Segmentation
1.3.1 Global Embolization Agents Market – By Product
1.3.2 Global Embolization Agents Market – By Application
1.3.3 Global Embolization Agents Market – By End User
1.3.4 Global Embolization Agents Market – By Geography
2. Global Embolization Agents Market – Key Takeaways
3. Research Methodology
3.1 Coverage
3.2 Secondary Research
3.3 Primary Research
4. Embolization Agents Market – Market Landscape
4.1 Overview
4.2 PEST Analysis
4.2.1 North America – PEST Analysis
4.2.2 Europe– PEST Analysis
4.2.3 Asia Pacific – PEST Analysis
4.2.4 Middle East and Africa – PEST Analysis
4.2.5 South and Central America (SCAM) – PEST Analysis
4.3 Experts Opinion
5. Embolization Agents Market– Key Market Dynamics
5.1 Market Drivers
5.1.1 Rise in the Incidence of Tumors and Aneurysms
5.1.2 Growing Incidence of Hypertension, Obesity, Smoking, and Alcoholism
5.2 Market Restraints
5.2.1 High Cost of Embolization Agents
5.3 Market Opportunities
5.3.1 Growing Geriatric Population Base
5.4 Future Trends
5.4.1 Technological Advancements in Embolization Products and Procedures
5.5 Impact analysis
6. Embolization Agents Market – Global Analysis
6.1 Global Embolization Agents Market Revenue Forecast and Analysis
6.2 Global Embolization Agents Market, By Geography - Forecast and Analysis
6.3 Market Positioning of Key Players
7. Embolization Agents Market Analysis – By Product
7.1 Overview
7.2 Embolization Agents Market Revenue Share, by Products (2021 and 2028)
7.3 Coils
7.3.1 Overview
7.3.2 Coils: Embolization Agents Market– Revenue and Forecast to 2028 (US$ Million)
7.3.2.1 Detachable Coils
7.3.2.1.1 Detachable Coil Market Revenue and Forecast to 2028 (US$ Mn)
7.3.2.1.2 Detachable Coil Market Revenue and Forecasts to 2028 (US$ Mn)
7.3.2.2 Pushable Coils
7.3.2.2.1 Pushable Coil Market Revenue and Forecast to 2028 (US$ Mn)
7.3.2.2.2 Pushable Coil Market Revenue and Forecasts to 2028 (US$ Mn)
7.4 Beads/Particles
7.4.1 Overview
7.4.2 Beads/Particles: Embolization Agents Market– Revenue and Forecast to 2028 (US$ Million)
7.4.2.1 Spherical
7.4.2.1.1 Spherical Market Revenue and Forecast to 2028 (US$ Mn)
7.4.2.1.2 Spherical Market Revenue and Forecasts to 2028 (US$ Mn)
7.4.2.2 Non-Spherical
7.4.2.2.1 Non-Spherical Market Revenue and Forecast to 2028 (US$ Mn)
7.4.2.2.2 Non-Spherical Market Revenue and Forecasts to 2028 (US$ Mn)
7.5 Plugs
7.5.1 Overview
7.5.2 Plugs: Embolization Agents Market– Revenue and Forecast to 2028 (US$ Million)
7.6 Detachable Balloons
7.6.1 Overview
7.6.2 Detachable Balloons: Embolization Agents Market– Revenue and Forecast to 2028 (US$ Million)
7.7 Glue
7.7.1 Overview
7.7.2 Glue: Embolization Agents Market– Revenue and Forecast to 2028 (US$ Million)
7.8 Sponge
7.8.1 Overview
7.8.2 Sponge: Embolization Agents Market– Revenue and Forecast to 2028 (US$ Million)
7.9 Liquid Embolics
7.9.1 Overview
7.9.2 Liquid Embolics: Embolization Agents Market– Revenue and Forecast to 2028 (US$ Million)
7.10 Sclerosants
7.10.1 Overview
7.10.2 Sclerosants: Embolization Agents Market– Revenue and Forecast to 2028 (US$ Million)
7.11 Precipitating Agents
7.11.1 Overview
7.11.2 Precipitating Agents: Embolization Agents Market– Revenue and Forecast to 2028 (US$ Million)
7.12 Others
7.12.1 Overview
7.12.2 Others: Embolization Agents Market– Revenue and Forecast to 2028 (US$ Million)
8. Embolization Agents Market Analysis – By Application
8.1 Overview
8.2 Embolization Agents Market, by Application 2021 & 2028 (%)
8.3 Oncology
8.3.1 Overview
8.3.2 Oncology: Embolization Agents Market – Revenue and Forecast to 2028 (US$ Million)
8.4 Neurology
8.4.1 Overview
8.4.2 Neurology: Embolization Agents Market – Revenue and Forecast to 2028 (US$ Million)
8.5 Urology
8.5.1 Overview
8.5.2 Urology: Embolization Agents Market – Revenue and Forecast to 2028 (US$ Million)
8.6 Cardiology
8.6.1 Overview
8.6.2 Cardiology: Embolization Agents Market – Revenue and Forecast to 2028 (US$ Million)
8.7 Peripheral Vascular Diseases
8.7.1 Overview
8.7.2 Peripheral Vascular Diseases: Embolization Agents Market – Revenue and Forecast to 2028 (US$ Million)
8.8 Others
8.8.1 Overview
8.8.2 Others: Embolization Agents Market – Revenue and Forecast to 2028 (US$ Million)
9. Embolization Agents Market Analysis – By End User
9.1 Overview
9.2 Embolization Agents Market Revenue Share, By End User (2021 and 2028)
9.3 Hospitals
9.3.1 Overview
9.3.2 Hospitals: Embolization Agents Market – Revenue and Forecast to 2028 (US$ Million)
9.4 Cardiac Centers
9.4.1 Overview
9.4.2 Cardiac Centers: Embolization Agents Market – Revenue and Forecast to 2028 (US$ Million)
9.5 Ambulatory Surgical Centers
9.5.1 Overview
9.5.2 Ambulatory Surgical Centers: Embolization Agents Market – Revenue and Forecast to 2028 (US$ Million)
9.6 Others
9.6.1 Overview
9.6.2 Others: Embolization Agents Market – Revenue and Forecast to 2028 (US$ Million)
10. Global Embolization Agents Market – Geographic Analysis
10.1 North America: Embolization Agents Market
10.1.1 Overview
10.1.2 North America: Embolization Agents Market - Revenue and Forecast to 2028 (USD Million)
10.1.3 North America Embolization Agents Market, by Product – Revenue and Forecast to 2028 (USD Million)
10.1.3.1 North America Embolization Agents Market, by Coil – Revenue and Forecast to 2028 (USD Million)
10.1.3.2 North America Embolization Agents Market, by Beads/ Particles – Revenue and Forecast to 2028 (USD Million)
10.1.4 North America Embolization Agents Market, By Application – Revenue and Forecast to 2028 (USD Million)
10.1.5 North America Embolization Agents Market, by End User – Revenue and Forecast to 2028 (USD Million)
10.1.6 North America: Embolization Agents Market, by Country, 2021 & 2028 (%)
10.1.6.1 US: Embolization Agents Market – Revenue and Forecast to 2028 (USD Million)
10.1.6.1.1 US: Embolization Agents Market – Revenue and Forecast to 2028 (USD Million)
10.1.6.1.2 US Embolization Agents Market, by Product – Revenue and Forecast to 2028 (USD Million)
10.1.6.1.2.1 US Embolization Agents Market, by Coil – Revenue and Forecast to 2028 (USD Million)
10.1.6.1.2.2 US Embolization Agents Market, by Beads/ Particles – Revenue and Forecast to 2028 (USD Million)
10.1.6.1.3 US Embolization Agents Market, By Application – Revenue and Forecast to 2028 (USD Million)
10.1.6.1.4 US Embolization Agents Market, by End User – Revenue and Forecast to 2028 (USD Million)
10.1.6.2 Canada: Embolization Agents Market – Revenue and Forecast to 2028 (USD Million)
10.1.6.2.1 Canada: Embolization Agents Market – Revenue and Forecast to 2028 (USD Million)
10.1.6.2.2 Canada Embolization Agents Market, by Product – Revenue and Forecast to 2028 (USD Million)
10.1.6.2.2.1 Canada Embolization Agents Market, by Coil – Revenue and Forecast to 2028 (USD Million)
10.1.6.2.2.2 Canada Embolization Agents Market, by Beads/ Particles – Revenue and Forecast to 2028 (USD Million)
10.1.6.2.3 Canada Embolization Agents Market, By Application – Revenue and Forecast to 2028 (USD Million)
10.1.6.2.4 Canada Embolization Agents Market, by End User – Revenue and Forecast to 2028 (USD Million)
10.1.6.3 Mexico: Embolization Agents Market – Revenue and Forecast to 2028 (USD Million)
10.1.6.3.1 Mexico: Embolization Agents Market – Revenue and Forecast to 2028 (USD Million)
10.1.6.3.2 Mexico Embolization Agents Market, by Product – Revenue and Forecast to 2028 (USD Million)
10.1.6.3.2.1 Mexico Embolization Agents Market, by Coil – Revenue and Forecast to 2028 (USD Million)
10.1.6.3.2.2 Mexico Embolization Agents Market, by Beads/ Particles – Revenue and Forecast to 2028 (USD Million)
10.1.6.3.3 Mexico Embolization Agents Market, By Application – Revenue and Forecast to 2028 (USD Million)
10.1.6.3.4 Mexico Embolization Agents Market, by End User – Revenue and Forecast to 2028 (USD Million)
10.2 Europe: Embolization Agents Market
10.2.1 Overview
10.2.2 Europe: Embolization Agents Market– Revenue and Forecast to 2028 (US$ Million)
10.2.3 Europe: Embolization Agents Market, by Product– Revenue and Forecast to 2028 (USD Million)
10.2.3.1 Europe: Embolization Agents Market, by Coils – Revenue and Forecast to 2028 (USD Million)
10.2.3.2 Europe Embolization Agents Market, by Beads/ Particles – Revenue and Forecast to 2028 (USD Million)
10.2.4 Europe: Embolization Agents Market, by Application – Revenue and Forecast to 2028 (US$ Million)
10.2.5 Europe: Embolization Agents Market, by End User – Revenue and Forecast to 2028 (US$ Million)
10.2.6 Europe: Embolization Agents Market, by Country, 2021 & 2028 (%)
10.2.6.1 Germany: Embolization Agents Market– Revenue and Forecast to 2028 (US$ Million)
10.2.6.1.1 Germany: Embolization Agents Market– Revenue and Forecast to 2028 (US$ Million)
10.2.6.1.2 Germany: Embolization Agents Market, by Product– Revenue and Forecast to 2028 (US$ Million)
10.2.6.1.2.1 Germany: Embolization Agents Market, by Coils– Revenue and Forecast to 2028 (USD Million)
10.2.6.1.2.2 Germany Embolization Agents Market, by Beads/ Particles – Revenue and Forecast to 2028 (USD Million)
10.2.6.1.3 Germany: Embolization Agents Market, by Application – Revenue and Forecast to 2028 (US$ Million)
10.2.6.1.4 Germany: Embolization Agents Market, by End User – Revenue and Forecast to 2028 (US$ Million)
10.2.6.2 France: Embolization Agents Market– Revenue and Forecast to 2028 (US$ Million)
10.2.6.2.1 France: Embolization Agents Market– Revenue and Forecast to 2028 (US$ Million)
10.2.6.2.2 France: Embolization Agents Market, by Product – Revenue and Forecast to 2028 (US$ Million)
10.2.6.2.2.1 France: Embolization Agents Market, by Coils – Revenue and Forecast to 2028 (USD Million)
10.2.6.2.2.2 France: Embolization Agents Market, by Beads/ Particles – Revenue and Forecast to 2028 (USD Million)
10.2.6.2.3 France: Embolization Agents Market, by Application – Revenue and Forecast to 2028 (US$ Million)
10.2.6.2.4 France: Embolization Agents Market, by End User – Revenue and Forecast to 2028 (US$ Million)
10.2.6.3 UK: Embolization Agents Market– Revenue and Forecast to 2028 (US$ Million)
10.2.6.3.1 UK: Embolization Agents Market– Revenue and Forecast to 2028 (US$ Million)
10.2.6.3.2 UK: Embolization Agents Market, by Product – Revenue and Forecast to 2028 (US$ Million)
10.2.6.3.2.1 UK: Embolization Agents Market, by Coils – Revenue and Forecast to 2028 (USD Million)
10.2.6.3.2.2 UK: Embolization Agents Market, by Beads/ Particles – Revenue and Forecast to 2028 (USD Million)
10.2.6.3.3 UK: Embolization Agents Market, by Application – Revenue and Forecast to 2028 (US$ Million)
10.2.6.3.4 UK: Embolization Agents Market, by End User – Revenue and Forecast to 2028 (US$ Million)
10.2.6.4 Spain: Embolization Agents Market– Revenue and Forecast to 2028 (US$ Million)
10.2.6.4.1 Spain: Embolization Agents Market– Revenue and Forecast to 2028 (US$ Million)
10.2.6.4.2 Spain: Embolization Agents Market, by Product – Revenue and Forecast to 2028 (US$ Million)
10.2.6.4.2.1 Spain: Embolization Agents Market, by Coils – Revenue and Forecast to 2028 (USD Million)
10.2.6.4.3 Spain: Embolization Agents Market, by Beads/ Particles – Revenue and Forecast to 2028 (USD Million)
10.2.6.4.4 Spain: Embolization Agents Market, by Application – Revenue and Forecast to 2028 (US$ Million)
10.2.6.4.5 Spain: Embolization Agents Market, by End User – Revenue and Forecast to 2028 (US$ Million)
10.2.6.5 Italy: Embolization Agents Market– Revenue and Forecast to 2028 (US$ Million)
10.2.6.5.1 Italy: Embolization Agents Market– Revenue and Forecast to 2028 (US$ Million)
10.2.6.5.2 Italy: Embolization Agents Market, by Product – Revenue and Forecast to 2028 (US$ Million)
10.2.6.5.2.1 Italy: Embolization Agents Market, by Coils – Revenue and Forecast to 2028 (USD Million)
10.2.6.5.2.2 Italy: Embolization Agents Market, by Beads/ Particles – Revenue and Forecast to 2028 (USD Million)
10.2.6.5.3 Italy: Embolization Agents Market, by Application – Revenue and Forecast to 2028 (US$ Million)
10.2.6.5.4 Italy: Embolization Agents Market, by End User – Revenue and Forecast to 2028 (US$ Million)
10.2.6.6 Rest of Europe: Embolization Agents Market– Revenue and Forecast to 2028 (US$ Million)
10.2.6.6.1 Rest of Europe: Embolization Agents Market– Revenue and Forecast to 2028 (US$ Million)
10.2.6.6.2 Rest of Europe: Embolization Agents Market, by Product – Revenue and Forecast to 2028 (US$ Million)
10.2.6.6.2.1 Rest of Europe: Embolization Agents Market, by Coils – Revenue and Forecast to 2028 (USD Million)
10.2.6.6.2.2 Rest of Europe: Embolization Agents Market, by Beads/ Particles – Revenue and Forecast to 2028 (USD Million)
10.2.6.6.3 Rest of Europe: Embolization Agents Market, by Application – Revenue and Forecast to 2028 (US$ Million)
10.2.6.6.4 Rest of Europe: Embolization Agents Market, by End User – Revenue and Forecast to 2028 (US$ Million)
10.3 Asia Pacific: Embolization Agents Market
10.3.1 Overview
10.3.2 Asia Pacific: Embolization Agents Market - Revenue and Forecast to 2028 (USD Million)
10.3.3 Asia Pacific: Embolization Agents Market, by Product, 2019–2028 (USD Million)
10.3.3.1 Asia Pacific: Embolization Agents Market, By Coil, 2019–2028 (USD Million)
10.3.3.2 Asia Pacific: Embolization Agents Market, By Beads/ Particles, 2019–2028 (USD Million)
10.3.4 Asia Pacific: Embolization Agents Market, By Application, 2019–2028 (USD Million)
10.3.5 Asia Pacific: Embolization Agents Market, by End User, 2019–2028 (USD Million)
10.3.6 Asia Pacific: Embolization Agents Market, by Country, 2021 & 2028 (%)
10.3.6.1 China: Embolization Agents Market – Revenue and Forecast to 2028 (USD Million)
10.3.6.1.1 China: Embolization Agents Market – Revenue and Forecast to 2028 (USD Million)
10.3.6.1.2 China: Embolization Agents Market, by Product, 2019–2028 (USD Million)
10.3.6.1.2.1 China: Embolization Agents Market, By Coil, 2019–2028 (USD Million)
10.3.6.1.2.2 China: Embolization Agents Market, By Beads/ Particles, 2019–2028 (USD Million)
10.3.6.1.3 China: Embolization Agents Market, By Application, 2019–2028 (USD Million)
10.3.6.1.4 China: Embolization Agents Market, by End User, 2019–2028 (USD Million)
10.3.6.2 Japan: Embolization Agents Market – Revenue and Forecast to 2028 (USD Million)
10.3.6.2.1 Japan: Embolization Agents Market – Revenue and Forecast to 2028 (USD Million)
10.3.6.2.2 Japan: Embolization Agents Market, by Product, 2019–2028 (USD Million)
10.3.6.2.2.1 Japan: Embolization Agents Market, by Coil, 2019–2028 (USD Million)
10.3.6.2.2.2 Japan: Embolization Agents Market, By Beads/ Particles, 2019–2028 (USD Million)
10.3.6.2.3 Japan: Embolization Agents Market, By Application, 2019–2028 (USD Million)
10.3.6.2.4 Japan: Embolization Agents Market, by End User, 2019–2028 (USD Million)
10.3.6.3 India: Embolization Agents Market – Revenue and Forecast to 2028 (USD Million)
10.3.6.3.1 India: Embolization Agents Market – Revenue and Forecast to 2028 (USD Million)
10.3.6.3.2 India: Embolization Agents Market, by Product, 2019–2028 (USD Million)
10.3.6.3.2.1 India: Embolization Agents Market, By Coil, 2019–2028 (USD Million)
10.3.6.3.2.2 India: Embolization Agents Market, By Beads/ Particles, 2019–2028 (USD Million)
10.3.6.3.3 India: Embolization Agents Market, By Application, 2019–2028 (USD Million)
10.3.6.3.4 India: Embolization Agents Market, by End User, 2019–2028 (USD Million)
10.3.6.4 Australia: Embolization Agents Market – Revenue and Forecast to 2028 (USD Million)
10.3.6.4.1 Australia: Embolization Agents Market – Revenue and Forecast to 2028 (USD Million)
10.3.6.4.2 Australia: Embolization Agents Market, by Product, 2019–2028 (USD Million)
10.3.6.4.2.1 Australia: Embolization Agents Market, By Coil, 2019–2028 (USD Million)
10.3.6.4.2.2 Australia: Embolization Agents Market, By Beads/ Particles, 2019–2028 (USD Million)
10.3.6.4.3 Australia: Embolization Agents Market, By Application, 2019–2028 (USD Million)
10.3.6.4.4 Australia: Embolization Agents Market, by End User, 2019–2028 (USD Million)
10.3.6.5 South Korea: Embolization Agents Market – Revenue and Forecast to 2028 (USD Million)
10.3.6.5.1 South Korea: Embolization Agents Market – Revenue and Forecast to 2028 (USD Million)
10.3.6.5.2 South Korea: Embolization Agents Market, by Product, 2019–2028 (USD Million)
10.3.6.5.2.1 South Korea: Embolization Agents Market, by Coil, 2019–2028 (USD Million)
10.3.6.5.2.2 South Korea: Embolization Agents Market, by Beads/ Particles, 2019–2028 (USD Million)
10.3.6.5.3 South Korea: Embolization Agents Market, By Application, 2019–2028 (USD Million)
10.3.6.5.4 South Korea: Embolization Agents Market, by End User, 2019–2028 (USD Million)
10.3.6.6 Rest of Asia Pacific: Embolization Agents Market – Revenue and Forecast to 2028 (USD Million)
10.3.6.6.1 Rest of Asia Pacific: Embolization Agents Market – Revenue and Forecast to 2028 (USD Million)
10.3.6.6.2 Rest of Asia Pacific: Embolization Agents Market, by Product, 2019–2028 (USD Million)
10.3.6.6.2.1 Rest of Asia Pacific: Embolization Agents Market, by Coil, 2019–2028 (USD Million)
10.3.6.6.2.2 Rest of Asia Pacific: Embolization Agents Market, by Beads/ Particles, 2019–2028 (USD Million)
10.3.6.6.3 Rest of Asia Pacific: Embolization Agents Market, By Application, 2019–2028 (USD Million)
10.3.6.6.4 Rest of Asia Pacific: Embolization Agents Market, by End User, 2019–2028 (USD Million)
10.4 Middle East and Africa: Embolization Agents Market
10.4.1 Overview
10.4.2 Middle East & Africa: Embolization Agents Market- Revenue and Forecast to 2028 (US$ Million)
10.4.3 Middle East and Africa Embolization Agents Market, By Product– Revenue and Forecast to 2028 (USD Million)
10.4.3.1 Middle East and Africa Embolization Agents Market, By Coil – Revenue and Forecast to 2028 (USD Million)
10.4.3.2 Middle East and Africa Embolization Agents Market, By Beads/ Particles – Revenue and Forecast to 2028 (USD Million)
10.4.4 Middle East and Africa Embolization Agents Market, By Application– Revenue and Forecast to 2028 (USD Million)
10.4.5 Middle East and Africa Embolization Agents Market, By End User – Revenue and Forecast to 2028 (USD Million)
10.4.6 Middle East and Africa: Embolization Agents Market, by Country, 2021 & 2028 (%)
10.4.6.1 Saudi Arabia: Embolization Agents Market– Revenue and Forecast to 2028 (US$ Million)
10.4.6.1.1 Saudi Arabia: Embolization Agents Market– Revenue and Forecast to 2028 (US$ Million)
10.4.6.1.2 Saudi Arabia Embolization Agents Market, By Product– Revenue and Forecast to 2028 (USD Million)
10.4.6.1.2.1 Saudi Arabia: Embolization Agents Market, by Coil, 2019–2028 (USD Million)
10.4.6.1.2.2 Saudi Arabia: Embolization Agents Market, by Coil, 2019–2028 (USD Million)
10.4.6.1.3 Saudi Arabia Embolization Agents Market, By Application– Revenue and Forecast to 2028 (USD Million)
10.4.6.1.4 Saudi Arabia Embolization Agents Market, By End User – Revenue and Forecast to 2028 (USD Million)
10.4.6.2 UAE: Embolization Agents Market– Revenue and Forecast to 2028 (US$ Million)
10.4.6.2.1 UAE: Embolization Agents Market– Revenue and Forecast to 2028 (US$ Million)
10.4.6.2.2 UAE Embolization Agents Market, By Product– Revenue and Forecast to 2028 (USD Million)
10.4.6.2.2.1 UAE: Embolization Agents Market, by Coil, 2019–2028 (USD Million)
10.4.6.2.2.2 UAE: Embolization Agents Market, by Beads/ Particles, 2019–2028 (USD Million)
10.4.6.2.3 UAE Embolization Agents Market, By Application– Revenue and Forecast to 2028 (USD Million)
10.4.6.2.4 UAE Embolization Agents Market, By End User – Revenue and Forecast to 2028 (USD Million)
10.4.6.3 South Africa: Embolization Agents Market– Revenue and Forecast to 2028 (US$ Million)
10.4.6.3.1 South Africa: Embolization Agents Market– Revenue and Forecast to 2028 (US$ Million)
10.4.6.3.2 South Africa Embolization Agents Market, By Product– Revenue and Forecast to 2028 (USD Million)
10.4.6.3.2.1 South Africa: Embolization Agents Market, by Coil, 2019–2028 (USD Million)
10.4.6.3.2.2 South Africa: Embolization Agents Market, by Beads/ Particles, 2019–2028 (USD Million)
10.4.6.3.3 South Africa Embolization Agents Market, By Application– Revenue and Forecast to 2028 (USD Million)
10.4.6.3.4 South Africa Embolization Agents Market, By End User – Revenue and Forecast to 2028 (USD Million)
10.4.6.4 Rest of Middle East and Africa: Embolization Agents Market– Revenue and Forecast to 2028 (US$ Million)
10.4.6.4.1 Rest of Middle East and Africa: Embolization Agents Market– Revenue and Forecast to 2028 (US$ Million)
10.4.6.4.2 Rest of Middle East and Africa Embolization Agents Market, By Product– Revenue and Forecast to 2028 (USD Million)
10.4.6.4.2.1 Rest of Middle East and Africa: Embolization Agents Market, by Coil, 2019–2028 (USD Million)
10.4.6.4.2.2 Rest of Middle East and Africa: Embolization Agents Market, by Beads/ Particles, 2019–2028 (USD Million)
10.4.6.4.3 Rest of Middle East and Africa Embolization Agents Market, By Application– Revenue and Forecast to 2028 (USD Million)
10.4.6.4.4 Rest of Middle East and Africa Embolization Agents Market, By End User – Revenue and Forecast to 2028 (USD Million)
10.5 South and Central America: Embolization Agents Market
10.5.1 Overview
10.5.2 South and Central America: Embolization Agents Market- Revenue and Forecast to 2028 (USD Million)
10.5.3 South and Central America: Embolization Agents Market, by Product – Revenue and Forecast to 2028 (US$ Million)
10.5.3.1 South and Central America: Embolization Agents Market, by Coils – Revenue and Forecast to 2028 (USD Million)
10.5.3.2 South and Central America: Embolization Agents Market, by Beads/ Particles – Revenue and Forecast to 2028 (USD Million)
10.5.4 South and Central America: Embolization Agents Market, by Application – Revenue and Forecast to 2028 (US$ Million)
10.5.5 South and Central America: Embolization Agents Market, by End User – Revenue and Forecast to 2028 (US$ Million)
10.5.6 South and Central America Embolization Agents Market, by Country, 2021 & 2028 (%)
10.5.6.1 Brazil: Embolization Agents Market– Revenue and Forecast to 2028 (US$ Million)
10.5.6.1.1 Brazil: Embolization Agents Market– Revenue and Forecast to 2028 (US$ Million)
10.5.6.1.2 Brazil: Embolization Agents Market, by Product – Revenue and Forecast to 2028 (US$ Million)
10.5.6.1.2.1 Brazil: Embolization Agents Market, by Coils – Revenue and Forecast to 2028 (USD Million)
10.5.6.1.2.2 Brazil: Embolization Agents Market, by Beads/ Particles – Revenue and Forecast to 2028 (USD Million)
10.5.6.1.3 Brazil: Embolization Agents Market, by Application – Revenue and Forecast to 2028 (US$ Million)
10.5.6.1.4 Brazil: Embolization Agents Market, by End User – Revenue and Forecast to 2028 (US$ Million)
10.5.6.2 Argentina: Embolization Agents Market– Revenue and Forecast to 2028 (US$ Million)
10.5.6.2.1 Argentina: Embolization Agents Market– Revenue and Forecast to 2028 (US$ Million)
10.5.6.2.2 Argentina: Embolization Agents Market, by Product – Revenue and Forecast to 2028 (US$ Million)
10.5.6.2.2.1 Argentina: Embolization Agents Market, by Coils – Revenue and Forecast to 2028 (USD Million)
10.5.6.2.2.2 Brazil: Embolization Agents Market, by Beads/ Particles – Revenue and Forecast to 2028 (USD Million)
10.5.6.2.3 Argentina: Embolization Agents Market, by Application – Revenue and Forecast to 2028 (US$ Million)
10.5.6.2.4 Argentina: Embolization Agents Market, by End User – Revenue and Forecast to 2028 (US$ Million)
10.5.6.3 Rest of South and Central America: Embolization Agents Market– Revenue and Forecast to 2028 (US$ Million)
10.5.6.3.1 Rest of South and Central America: Embolization Agents Market– Revenue and Forecast to 2028 (US$ Million)
10.5.6.3.2 Rest of South and Central America: Embolization Agents Market, by Product – Revenue and Forecast to 2028 (US$ Million)
10.5.6.3.2.1 Rest of South and Central America: Embolization Agents Market, by Coils – Revenue and Forecast to 2028 (US$ Million)
10.5.6.3.3 Rest of South and Central America: Embolization Agents Market, by Beads/ Particles – Revenue and Forecast to 2028 (USD Million)
10.5.6.3.4 Rest of South and Central America: Embolization Agents Market, by Application – Revenue and Forecast to 2028 (US$ Million)
10.5.6.3.5 Rest of South and Central America: Embolization Agents Market, by End User – Revenue and Forecast to 2028 (US$ Million)
11. Impact Of COVID-19 Pandemic on Embolization Agents Market
11.1 North America: Impact Assessment of COVID-19 Pandemic
11.2 Europe: Impact Assessment Of COVID-19 Pandemic
11.3 Asia Pacific: Impact Assessment of COVID-19 Pandemic
11.4 Middle East and Africa: Impact Assessment of COVID-19 Pandemic
11.5 South & Central America: Impact Assessment of COVID-19 Pandemic
12. Embolization Agents Market–Industry Landscape
12.1 Overview
12.2 Growth Strategies Done by the Companies in the Market, (%)
12.3 Organic Developments
12.3.1 Overview
12.4 Inorganic Developments
12.4.1 Overview
13. Company Profiles
13.1 Medtronic
13.1.1 Key Facts
13.1.2 Business Description
13.1.3 Products and Services
13.1.4 Financial Overview
13.1.5 SWOT Analysis
13.1.6 Key Developments
13.2 Terumo Corporation
13.2.1 Key Facts
13.2.2 Business Description
13.2.3 Products and Services
13.2.4 Financial Overview
13.2.5 SWOT Analysis
13.2.6 Key Developments
13.3 Cook Medical LLC
13.3.1 Key Facts
13.3.2 Business Description
13.3.3 Products and Services
13.3.4 Financial Overview
13.3.5 SWOT Analysis
13.3.6 Key Developments
13.4 Boston Scientific Corporation
13.4.1 Key Facts
13.4.2 Business Description
13.4.3 Products and Services
13.4.4 Financial Overview
13.4.5 SWOT Analysis
13.4.6 Key Developments
13.5 Abbott
13.5.1 Key Facts
13.5.2 Business Description
13.5.3 Products and Services
13.5.4 Financial Overview
13.5.5 SWOT Analysis
13.5.6 Key Developments
13.6 Stryker Corporation
13.6.1 Key Facts
13.6.2 Business Description
13.6.3 Products and Services
13.6.4 Financial Overview
13.6.5 SWOT Analysis
13.6.6 Key Developments
13.7 Penumbra, Inc.
13.7.1 Key Facts
13.7.2 Business Description
13.7.3 Products and Services
13.7.4 Financial Overview
13.7.5 SWOT Analysis
13.7.6 Key Developments
13.8 Merit Medical Systems Inc.
13.8.1 Key Facts
13.8.2 Business Description
13.8.3 Products and Services
13.8.4 Financial Overview
13.8.5 SWOT Analysis
13.8.6 Key Developments
13.9 DePuy Synthes
13.9.1 Key Facts
13.9.2 Business Description
13.9.3 Products and Services
13.9.4 Financial Overview
13.9.5 SWOT Analysis
13.9.6 Key Developments
13.10 KANEKA CORPORATION
13.10.1 Key Facts
13.10.2 Business Description
13.10.3 Products and Services
13.10.4 Financial Overview
13.10.5 SWOT Analysis
13.10.6 Key Developments
14. Appendix
14.1 About The Insight Partners
14.2 Glossary of Terms
LIST OF TABLES
Table 1. North America Embolization Agents Market, by Product – Revenue and Forecast to 2028 (USD Million)
Table 2. North America Embolization Agents Market, by Coil – Revenue and Forecast to 2028 (USD Million)
Table 3. North America Embolization Agents Market, by Beads/ Particles – Revenue and Forecast to 2028 (USD Million)
Table 4. North America Embolization Agents Market, By Application – Revenue and Forecast to 2028 (USD Million)
Table 5. North America Embolization Agents Market, by End User – Revenue and Forecast to 2028 (USD Million)
Table 6. US Embolization Agents Market, by Product – Revenue and Forecast to 2028 (USD Million)
Table 7. US Embolization Agents Market, by Coil – Revenue and Forecast to 2028 (USD Million)
Table 8. US Embolization Agents Market, by Beads/ Particles – Revenue and Forecast to 2028 (USD Million)
Table 9. US Embolization Agents Market, By Application – Revenue and Forecast to 2028 (USD Million)
Table 10. US Embolization Agents Market, by End User – Revenue and Forecast to 2028 (USD Million)
Table 11. Canada Embolization Agents Market, by Product - Revenue and Forecast to 2028 (USD Million)
Table 12. Canada Embolization Agents Market, by Coil - Revenue and Forecast to 2028 (USD Million)
Table 13. Canada Embolization Agents Market, by Beads/ Particles - Revenue and Forecast to 2028 (USD Million)
Table 14. Canada Embolization Agents Market, By Application - Revenue and Forecast to 2028 (USD Million)
Table 15. Canada Embolization Agents Market, by End User – Revenue and Forecast to 2028 (USD Million)
Table 16. Mexico Embolization Agents Market, by Product – Revenue and Forecast to 2028 (USD Million)
Table 17. Mexico Embolization Agents Market, by Coil – Revenue and Forecast to 2028 (USD Million)
Table 18. Mexico Embolization Agents Market, by Beads/ Particles – Revenue and Forecast to 2028 (USD Million)
Table 19. Mexico Embolization Agents Market, By Application – Revenue and Forecast to 2028 (USD Million)
Table 20. Mexico Embolization Agents Market, by End User – Revenue and Forecast to 2028 (USD Million)
Table 21. Europe: Embolization Agents Market, by Product – Revenue and Forecast to 2028 (US$ Million)
Table 22. Europe: Embolization Agents Market, by Coils – Revenue and Forecast to 2028 (USD Million)
Table 23. Europe Embolization Agents Market, by Beads/ Particles – Revenue and Forecast to 2028 (USD Million)
Table 24. Europe: Embolization Agents Market, by Application – Revenue and Forecast to 2028 (US$ Million)
Table 25. Europe: Embolization Agents Market, by End User – Revenue and Forecast to 2028 (US$ Million)
Table 26. Germany: Embolization Agents Market, by Product – Revenue and Forecast to 2028 (US$ Million)
Table 27. Germany: Embolization Agents Market, by Coils– Revenue and Forecast to 2028 (USD Million)
Table 28. Germany Embolization Agents Market, by Beads/ Particles – Revenue and Forecast to 2028 (USD Million)
Table 29. Germany: Embolization Agents Market, by Application – Revenue and Forecast to 2028 (US$ Million)
Table 30. Germany: Embolization Agents Market, by End User – Revenue and Forecast to 2028 (US$ Million)
Table 31. France: Embolization Agents Market, by Product – Revenue and Forecast to 2028 (US$ Million)
Table 32. France: Embolization Agents Market, by Coils – Revenue and Forecast to 2028 (USD Million)
Table 33. France: Embolization Agents Market, by Beads/ Particles – Revenue and Forecast to 2028 (USD Million)
Table 34. France: Embolization Agents Market, by Application – Revenue and Forecast to 2028 (US$ Million)
Table 35. France: Embolization Agents Market, by End User – Revenue and Forecast to 2028 (US$ Million)
Table 36. UK: Embolization Agents Market, by Product – Revenue and Forecast to 2028 (US$ Million)
Table 37. UK: Embolization Agents Market, by Coils – Revenue and Forecast to 2028 (USD Million)
Table 38. UK: Embolization Agents Market, by Beads/ Particles – Revenue and Forecast to 2028 (USD Million)
Table 39. UK: Embolization Agents Market, by Application – Revenue and Forecast to 2028 (US$ Million)
Table 40. UK: Embolization Agents Market, by End User – Revenue and Forecast to 2028 (US$ Million)
Table 41. Spain: Embolization Agents Market, by Product – Revenue and Forecast to 2028 (US$ Million)
Table 42. Spain: Embolization Agents Market, by Coils – Revenue and Forecast to 2028 (USD Million)
Table 43. Spain: Embolization Agents Market, by Beads/ Particles – Revenue and Forecast to 2028 (USD Million)
Table 44. Spain: Embolization Agents Market, by Application – Revenue and Forecast to 2028 (US$ Million)
Table 45. Spain: Embolization Agents Market, by End User – Revenue and Forecast to 2028 (US$ Million)
Table 46. Italy: Embolization Agents Market, by Product – Revenue and Forecast to 2028 (US$ Million)
Table 47. Italy: Embolization Agents Market, by Coils – Revenue and Forecast to 2028 (USD Million)
Table 48. Italy: Embolization Agents Market, by Beads/ Particles – Revenue and Forecast to 2028 (USD Million)
Table 49. Italy: Embolization Agents Market, by Application – Revenue and Forecast to 2028 (US$ Million)
Table 50. Italy: Embolization Agents Market, by End User – Revenue and Forecast to 2028 (US$ Million)
Table 51. Rest of Europe: Embolization Agents Market, by Product – Revenue and Forecast to 2028 (US$ Million)
Table 52. Rest of Europe: Embolization Agents Market, by Coils – Revenue and Forecast to 2028 (USD Million)
Table 53. Rest of Europe: Embolization Agents Market, by Beads/ Particles – Revenue and Forecast to 2028 (USD Million)
Table 54. Rest of Europe: Embolization Agents Market, by Application – Revenue and Forecast to 2028 (US$ Million)
Table 55. Rest of Europe: Embolization Agents Market, by End User – Revenue and Forecast to 2028 (US$ Million)
Table 56. Asia Pacific: Embolization Agents Market, by Product – Revenue and Forecast to 2028 (USD Million)
Table 57. Asia Pacific Embolization Agents Market, By Coil – Revenue and Forecast to 2028 (USD Million)
Table 58. Asia Pacific Embolization Agents Market, By Beads/ Particles – Revenue and Forecast to 2028 (USD Million)
Table 59. Asia Pacific Embolization Agents Market, By Application – Revenue and Forecast to 2028 (USD Million)
Table 60. Asia Pacific Embolization Agents Market, by End User– Revenue and Forecast to 2028 (USD Million)
Table 61. China: Embolization Agents Market, by Product – Revenue and Forecast to 2028 (USD Million)
Table 62. China: Embolization Agents Market, By Coil – Revenue and Forecast to 2028 (USD Million)
Table 63. China: Embolization Agents Market, By Beads/ Particles – Revenue and Forecast to 2028 (USD Million)
Table 64. China: Embolization Agents Market, By Application – Revenue and Forecast to 2028 (USD Million)
Table 65. China: Embolization Agents Market, by End User– Revenue and Forecast to 2028 (USD Million)
Table 66. Japan: Embolization Agents Market, by Product– Revenue and Forecast to 2028 (USD Million)
Table 67. Japan: Embolization Agents Market, by Coil – Revenue and Forecast to 2028 (USD Million)
Table 68. Japan: Embolization Agents Market, By Beads/ Particles – Revenue and Forecast to 2028 (USD Million)
Table 69. Japan: Embolization Agents Market, By Application – Revenue and Forecast to 2028 (USD Million)
Table 70. Japan: Embolization Agents Market, by End User – Revenue and Forecast to 2028 (USD Million)
Table 71. India: Embolization Agents Market, by Product– Revenue and Forecast to 2028 (USD Million)
Table 72. India: Embolization Agents Market, By Coil – Revenue and Forecast to 2028 (USD Million)
Table 73. India: Embolization Agents Market, By Beads/ Particles – Revenue and Forecast to 2028 (USD Million)
Table 74. India: Embolization Agents Market, By Application – Revenue and Forecast to 2028 (USD Million)
Table 75. India: Embolization Agents Market, by End User– Revenue and Forecast to 2028 (USD Million)
Table 76. Australia: Embolization Agents Market, by Product – Revenue and Forecast to 2028 (USD Million)
Table 77. Australia: Embolization Agents Market, By Coil – Revenue and Forecast to 2028 (USD Million)
Table 78. Australia: Embolization Agents Market, By Beads/ Particles – Revenue and Forecast to 2028 (USD Million)
Table 79. Australia: Embolization Agents Market, By Application – Revenue and Forecast to 2028 (USD Million)
Table 80. Australia: Embolization Agents Market, by End User– Revenue and Forecast to 2028 (USD Million)
Table 81. South Korea: Embolization Agents Market, by Product – Revenue and Forecast to 2028 (USD Million)
Table 82. South Korea: Embolization Agents Market, by Coil – Revenue and Forecast to 2028 (USD Million)
Table 83. South Korea: Embolization Agents Market, by Beads/ Particles – Revenue and Forecast to 2028 (USD Million)
Table 84. South Korea: Embolization Agents Market, By Application – Revenue and Forecast to 2028 (USD Million)
Table 85. South Korea: Embolization Agents Market, by End User– Revenue and Forecast to 2028 (USD Million)
Table 86. Rest of Asia Pacific: Embolization Agents Market, by Product – Revenue and Forecast to 2028 (USD Million)
Table 87. Rest of Asia Pacific: Embolization Agents Market, by Coil – Revenue and Forecast to 2028 (USD Million)
Table 88. Rest of Asia Pacific: Embolization Agents Market, by Beads/ Particles – Revenue and Forecast to 2028 (USD Million)
Table 89. Rest of Asia Pacific: Embolization Agents Market, By Application – Revenue and Forecast to 2028 (USD Million)
Table 90. Rest of Asia Pacific: Embolization Agents Market, by End User– Revenue and Forecast to 2028 (USD Million)
Table 91. Middle East and Africa Embolization Agents Market, By Product – Revenue and Forecast to 2028 (USD Million)
Table 92. Middle East and Africa Embolization Agents Market, By Coil – Revenue and Forecast to 2028 (USD Million)
Table 93. Middle East and Africa Embolization Agents Market, By Beads/ Particles – Revenue and Forecast to 2028 (USD Million)
Table 94. Middle East and Africa Embolization Agents Market, By Application– Revenue and Forecast to 2028 (USD Million)
Table 95. Middle East and Africa Embolization Agents Market, By End User – Revenue and Forecast to 2028 (USD Million)
Table 96. Saudi Arabia Embolization Agents Market, By Product – Revenue and Forecast to 2028 (USD Million)
Table 97. Saudi Arabia Embolization Agents Market, by Coil – Revenue and Forecast to 2028 (USD Million)
Table 98. Saudi Arabia Embolization Agents Market, by Coil – Revenue and Forecast to 2028 (USD Million)
Table 99. Saudi Arabia Embolization Agents Market, By Application– Revenue and Forecast to 2028 (USD Million)
Table 100. Saudi Arabia Embolization Agents Market, By End User – Revenue and Forecast to 2028 (USD Million)
Table 101. UAE Embolization Agents Market, By Product – Revenue and Forecast to 2028 (USD Million)
Table 102. UAE Embolization Agents Market, by Coil – Revenue and Forecast to 2028 (USD Million)
Table 103. UAE Embolization Agents Market, by Beads/ Particles – Revenue and Forecast to 2028 (USD Million)
Table 104. UAE Embolization Agents Market, By Application– Revenue and Forecast to 2028 (USD Million)
Table 105. UAE Embolization Agents Market, By End User – Revenue and Forecast to 2028 (USD Million)
Table 106. South Africa Embolization Agents Market, By Product – Revenue and Forecast to 2028 (USD Million)
Table 107. South Africa Embolization Agents Market, by Coil – Revenue and Forecast to 2028 (USD Million)
Table 108. South Africa Embolization Agents Market, by Beads/ Particles – Revenue and Forecast to 2028 (USD Million)
Table 109. South Africa Embolization Agents Market, By Application– Revenue and Forecast to 2028 (USD Million)
Table 110. South Africa Embolization Agents Market, By End User – Revenue and Forecast to 2028 (USD Million)
Table 111. Rest of Middle East and Africa Embolization Agents Market, By Product – Revenue and Forecast to 2028 (USD Million)
Table 112. Rest of Middle East and Africa Embolization Agents Market, by Coil – Revenue and Forecast to 2028 (USD Million)
Table 113. Rest of Middle East and Africa Embolization Agents Market, by Beads/ Particles – Revenue and Forecast to 2028 (USD Million)
Table 114. Rest of Middle East and Africa Embolization Agents Market, By Application– Revenue and Forecast to 2028 (USD Million)
Table 115. Rest of Middle East and Africa Embolization Agents Market, By End User – Revenue and Forecast to 2028 (USD Million)
Table 116. South and Central America: Embolization Agents Market, by Product – Revenue and Forecast to 2028 (US$ Million)
Table 117. South and Central America: Embolization Agents Market, by Coils – Revenue and Forecast to 2028 (USD Million)
Table 118. South and Central America: Embolization Agents Market, by Beads/ Particles – Revenue and Forecast to 2028 (USD Million)
Table 119. South and Central America: Embolization Agents Market, by Application – Revenue and Forecast to 2028 (US$ Million)
Table 120. South and Central America: Embolization Agents Market, by End User – Revenue and Forecast to 2028 (US$ Million)
Table 121. Brazil: Embolization Agents Market, by Product – Revenue and Forecast to 2028 (US$ Million)
Table 122. Brazil: Embolization Agents Market, by Coils – Revenue and Forecast to 2028 (USD Million)
Table 123. Brazil: Embolization Agents Market, by Beads/ Particles – Revenue and Forecast to 2028 (USD Million)
Table 124. Brazil: Embolization Agents Market, by Application – Revenue and Forecast to 2028 (US$ Million)
Table 125. Brazil: Embolization Agents Market, by End User – Revenue and Forecast to 2028 (US$ Million)
Table 126. Argentina: Embolization Agents Market, by Product – Revenue and Forecast to 2028 (US$ Million)
Table 127. Argentina: Embolization Agents Market, by Coils – Revenue and Forecast to 2028 (USD Million)
Table 128. Brazil: Embolization Agents Market, by Beads/ Particles – Revenue and Forecast to 2028 (USD Million)
Table 129. Argentina: Embolization Agents Market, by Application – Revenue and Forecast to 2028 (US$ Million)
Table 130. Argentina: Embolization Agents Market, by End User – Revenue and Forecast to 2028 (US$ Million)
Table 131. Rest of South and Central America: Embolization Agents Market, by Product – Revenue and Forecast to 2028 (US$ Million)
Table 132. Rest of South and Central America: Embolization Agents Market, by Coils – Revenue and Forecast to 2028 (US$ Million)
Table 133. Rest of South and Central America: Embolization Agents Market, by Beads/ Particles – Revenue and Forecast to 2028 (USD Million)
Table 134. Rest of South and Central America: Embolization Agents Market, by Application – Revenue and Forecast to 2028 (US$ Million)
Table 135. Rest of South and Central America: Embolization Agents Market, by End User – Revenue and Forecast to 2028 (US$ Million)
Table 136. Organic Developments Done by Companies
Table 137. Inorganic Developments Done by Companies
Table 138. Glossary of Terms, Embolization Agents Market
LIST OF FIGURES
Figure 1. Embolization Agents Market Segmentation
Figure 2. Embolization Agents Market Segmentation, By Region
Figure 3. Global Embolization Agents Market Overview
Figure 4. Beads/ Particles Segment Held the Largest Share of the Product Segment in Embolization Agents Market
Figure 5. Asia Pacific to Show Significant Growth During Forecast Period
Figure 6. Embolization Agents Market, by Geography (US$ Million)
Figure 7. Global Embolization Agents Market – Leading Country Markets (US$ Million)
Figure 8. Global Embolization Agents Market, Industry Landscape
Figure 9. North America PEST Analysis
Figure 10. Europe and PEST Analysis
Figure 11. Asia Pacific PEST Analysis
Figure 12. Middle East and Africa PEST Analysis
Figure 13. South and Central America (SCAM) PEST Analysis
Figure 14. Embolization Agents Market Impact Analysis of Drivers and Restraints
Figure 15. Global Embolization Agents Market – Revenue Forecast and Analysis – 2020- 2028
Figure 16. Global Embolization Agents Market – By Geography Forecast and Analysis – 2021- 2028
Figure 17. Market Positioning of Key Players in Global Embolization Agents Market
Figure 18. Embolization Agents Market Revenue Share, by Products (2021 and 2028)
Figure 19. Coils: Embolization Agents Market– Revenue and Forecast to 2028 (US$ Million)
Figure 20. Beads/Particles: Embolization Agents Market– Revenue and Forecast to 2028 (US$ Million)
Figure 21. Plugs: Embolization Agents Market– Revenue and Forecast to 2028 (US$ Million)
Figure 22. Detachable Balloons: Embolization Agents Market– Revenue and Forecast to 2028 (US$ Million)
Figure 23. Glue: Embolization Agents Market– Revenue and Forecast to 2028 (US$ Million)
Figure 24. Sponge: Embolization Agents Market– Revenue and Forecast to 2028 (US$ Million)
Figure 25. Liquid Embolics: Embolization Agents Market– Revenue and Forecast to 2028 (US$ Million)
Figure 26. Sclerosants: Embolization Agents Market– Revenue and Forecast to 2028 (US$ Million)
Figure 27. Precipitating Agents: Embolization Agents Market– Revenue and Forecast to 2028 (US$ Million)
Figure 28. Others: Embolization Agents Market– Revenue and Forecast to 2028 (US$ Million)
Figure 29. Embolization Agents Market, by Application 2021 & 2028 (%)
Figure 30. Oncology: Embolization Agents Market – Revenue and Forecast to 2028 (US$ Million)
Figure 31. Neurology: Embolization Agents Market – Revenue and Forecast to 2028 (US$ Million)
Figure 32. Urology: Embolization Agents Market – Revenue and Forecast to 2028 (US$ Million)
Figure 33. Cardiology: Embolization Agents Market – Revenue and Forecast to 2028 (US$ Million)
Figure 34. Peripheral Vascular Diseases: Embolization Agents Market – Revenue and Forecast to 2028 (US$ Million)
Figure 35. Others: Embolization Agents Market – Revenue and Forecast to 2028 (US$ Million)
Figure 36. Embolization Agents Market Revenue Share, By End User (2021 and 2028)
Figure 37. Hospitals: Embolization Agents Market – Revenue and Forecast to 2028 (US$ Million)
Figure 38. Cardiac Centers: Embolization Agents Market – Revenue and Forecast to 2028 (US$ Million)
Figure 39. Ambulatory Surgical Centers: Embolization Agents Market – Revenue and Forecast to 2028 (US$ Million)
Figure 40. Others: Embolization Agents Market – Revenue and Forecast to 2028 (US$ Million)
Figure 41. North America: Embolization Agents Market, by Key Country – Revenue (2021) (USD Million)
Figure 42. North America Embolization Agents Market Revenue and Forecast to 2028 (USD Million)
Figure 43. North America: Embolization Agents Market, by Country, 2021 & 2028 (%)
Figure 44. US: Embolization Agents Market – Revenue and Forecast to 2028 (USD Million)
Figure 45. Canada: Embolization Agents Market – Revenue and Forecast to 2028 (USD Million)
Figure 46. Mexico: Embolization Agents Market – Revenue and Forecast to 2028 (USD Million)
Figure 47. Europe: Embolization Agents Market, by Key Country – Revenue (2021) (USD Million)
Figure 48. Europe: Embolization Agents Market Revenue and Forecast to 2028 (US$ Million)
Figure 49. Europe: Embolization Agents Market, by Country, 2021 & 2028 (%)
Figure 50. Germany: Embolization Agents Market– Revenue and Forecast to 2028 (US$ Million)
Figure 51. France: Embolization Agents Market– Revenue and Forecast to 2028 (US$ Million)
Figure 52. UK: Embolization Agents Market– Revenue and Forecast to 2028 (US$ Million)
Figure 53. Spain: Embolization Agents Market– Revenue and Forecast to 2028 (US$ Million)
Figure 54. Italy: Embolization Agents Market– Revenue and Forecast to 2028 (US$ Million)
Figure 55. Rest of Europe: Embolization Agents Market– Revenue and Forecast to 2028 (US$ Million)
Figure 56. Asia Pacific: Embolization Agents Market, by Key Country – Revenue (2021) (USD Million)
Figure 57. Asia Pacific Embolization Agents Market Revenue and Forecast to 2028 (USD Million)
Figure 58. Asia Pacific: Embolization Agents Market, by Country, 2021 & 2028 (%)
Figure 59. China: Embolization Agents Market – Revenue and Forecast to 2028 (USD Million)
Figure 60. Japan: Embolization Agents Market – Revenue and Forecast to 2028 (USD Million)
Figure 61. India: Embolization Agents Market – Revenue and Forecast to 2028 (USD Million)
Figure 62. Australia: Embolization Agents Market – Revenue and Forecast to 2028 (USD Million)
Figure 63. South Korea: Embolization Agents Market – Revenue and Forecast to 2028 (USD Million)
Figure 64. Rest of Asia Pacific: Embolization Agents Market – Revenue and Forecast to 2028 (USD Million)
Figure 65. Middle East and Africa: Embolization Agents Market, by Key Country – Revenue (2021) (USD Million)
Figure 66. Middle East & Africa Embolization Agents Market Revenue and Forecast to 2028 (US$ Million)
Figure 67. Middle East and Africa: Embolization Agents Market, by Country, 2021 & 2028 (%)
Figure 68. Saudi Arabia: Embolization Agents Market– Revenue and Forecast to 2028 (US$ Million)
Figure 69. UAE: Embolization Agents Market– Revenue and Forecast to 2028 (US$ Million)
Figure 70. South Africa: Embolization Agents Market– Revenue and Forecast to 2028 (US$ Million)
Figure 71. Rest of Middle East and Africa: Embolization Agents Market– Revenue and Forecast to 2028 (US$ Million)
Figure 72. South and Central America: Embolization Agents Market, By Key Country – Revenue (2021) (USD Million)
Figure 73. South and Central America: Embolization Agents Market- Revenue and Forecasts To 2028 (USD Million)
Figure 74. South and Central America: Embolization Agents Market, by Country, 2021 & 2028 (%)
Figure 75. Brazil: Embolization Agents Market– Revenue and Forecast to 2028 (US$ Million)
Figure 76. Argentina: Embolization Agents Market– Revenue and Forecast to 2028 (US$ Million)
Figure 77. Rest of South and Central America: Embolization Agents Market– Revenue and Forecast to 2028 (US$ Million)
Figure 78. Impact of COVID-19 Pandemic in North American Country Markets
Figure 79. Impact of COVID-19 Pandemic in European Country Markets
Figure 80. Impact of COVID-19 Pandemic in European Country Markets
Figure 81. Impact of COVID-19 Pandemic in Middle East and Africa Country Markets
Figure 82. Impact of COVID-19 Pandemic in South & Central America Market
Figure 83. Growth Strategies Done by the Companies in the Market, (%)
The List of Companies - Embolization Agents Market
- Medtronic
- Terumo Corporation
- Cook Medical LLC
- Boston Scientific Corporation
- Abbott
- Stryker Corporation
- Penumbra, Inc.
- Merit Medical Systems Inc.
- DePuy Synthes
- KANEKA CORPORATION
The Insight Partners performs research in 4 major stages: Data Collection & Secondary Research, Primary Research, Data Analysis and Data Triangulation & Final Review.
- Data Collection and Secondary Research:
As a market research and consulting firm operating from a decade, we have published many reports and advised several clients across the globe. First step for any study will start with an assessment of currently available data and insights from existing reports. Further, historical and current market information is collected from Investor Presentations, Annual Reports, SEC Filings, etc., and other information related to company’s performance and market positioning are gathered from Paid Databases (Factiva, Hoovers, and Reuters) and various other publications available in public domain.
Several associations trade associates, technical forums, institutes, societies and organizations are accessed to gain technical as well as market related insights through their publications such as research papers, blogs and press releases related to the studies are referred to get cues about the market. Further, white papers, journals, magazines, and other news articles published in the last 3 years are scrutinized and analyzed to understand the current market trends.
- Primary Research:
The primarily interview analysis comprise of data obtained from industry participants interview and answers to survey questions gathered by in-house primary team.
For primary research, interviews are conducted with industry experts/CEOs/Marketing Managers/Sales Managers/VPs/Subject Matter Experts from both demand and supply side to get a 360-degree view of the market. The primary team conducts several interviews based on the complexity of the markets to understand the various market trends and dynamics which makes research more credible and precise.
A typical research interview fulfils the following functions:
- Provides first-hand information on the market size, market trends, growth trends, competitive landscape, and outlook
- Validates and strengthens in-house secondary research findings
- Develops the analysis team’s expertise and market understanding
Primary research involves email interactions and telephone interviews for each market, category, segment, and sub-segment across geographies. The participants who typically take part in such a process include, but are not limited to:
- Industry participants: VPs, business development managers, market intelligence managers and national sales managers
- Outside experts: Valuation experts, research analysts and key opinion leaders specializing in the electronics and semiconductor industry.
Below is the breakup of our primary respondents by company, designation, and region:
Once we receive the confirmation from primary research sources or primary respondents, we finalize the base year market estimation and forecast the data as per the macroeconomic and microeconomic factors assessed during data collection.
- Data Analysis:
Once data is validated through both secondary as well as primary respondents, we finalize the market estimations by hypothesis formulation and factor analysis at regional and country level.
- 3.1 Macro-Economic Factor Analysis:
We analyse macroeconomic indicators such the gross domestic product (GDP), increase in the demand for goods and services across industries, technological advancement, regional economic growth, governmental policies, the influence of COVID-19, PEST analysis, and other aspects. This analysis aids in setting benchmarks for various nations/regions and approximating market splits. Additionally, the general trend of the aforementioned components aid in determining the market's development possibilities.
- 3.2 Country Level Data:
Various factors that are especially aligned to the country are taken into account to determine the market size for a certain area and country, including the presence of vendors, such as headquarters and offices, the country's GDP, demand patterns, and industry growth. To comprehend the market dynamics for the nation, a number of growth variables, inhibitors, application areas, and current market trends are researched. The aforementioned elements aid in determining the country's overall market's growth potential.
- 3.3 Company Profile:
The “Table of Contents” is formulated by listing and analyzing more than 25 - 30 companies operating in the market ecosystem across geographies. However, we profile only 10 companies as a standard practice in our syndicate reports. These 10 companies comprise leading, emerging, and regional players. Nonetheless, our analysis is not restricted to the 10 listed companies, we also analyze other companies present in the market to develop a holistic view and understand the prevailing trends. The “Company Profiles” section in the report covers key facts, business description, products & services, financial information, SWOT analysis, and key developments. The financial information presented is extracted from the annual reports and official documents of the publicly listed companies. Upon collecting the information for the sections of respective companies, we verify them via various primary sources and then compile the data in respective company profiles. The company level information helps us in deriving the base number as well as in forecasting the market size.
- 3.4 Developing Base Number:
Aggregation of sales statistics (2020-2022) and macro-economic factor, and other secondary and primary research insights are utilized to arrive at base number and related market shares for 2022. The data gaps are identified in this step and relevant market data is analyzed, collected from paid primary interviews or databases. On finalizing the base year market size, forecasts are developed on the basis of macro-economic, industry and market growth factors and company level analysis.
- Data Triangulation and Final Review:
The market findings and base year market size calculations are validated from supply as well as demand side. Demand side validations are based on macro-economic factor analysis and benchmarks for respective regions and countries. In case of supply side validations, revenues of major companies are estimated (in case not available) based on industry benchmark, approximate number of employees, product portfolio, and primary interviews revenues are gathered. Further revenue from target product/service segment is assessed to avoid overshooting of market statistics. In case of heavy deviations between supply and demand side values, all thes steps are repeated to achieve synchronization.
We follow an iterative model, wherein we share our research findings with Subject Matter Experts (SME’s) and Key Opinion Leaders (KOLs) until consensus view of the market is not formulated – this model negates any drastic deviation in the opinions of experts. Only validated and universally acceptable research findings are quoted in our reports.
We have important check points that we use to validate our research findings – which we call – data triangulation, where we validate the information, we generate from secondary sources with primary interviews and then we re-validate with our internal data bases and Subject matter experts. This comprehensive model enables us to deliver high quality, reliable data in shortest possible time.